Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid aptamer specifically binding to metastatic gastric cancer cell, and application thereof

A nucleic acid aptamer, combined with metastasis technology, applied in tumor/cancer cells, animal cells, vertebrate cells, etc., can solve the death of cancer patients, and there is no nucleic acid aptamer that can distinguish metastatic gastric cancer cells from non-metastatic gastric cancer cells. Ligands, incurable metastatic cancer, etc.

Active Publication Date: 2018-12-04
安徽省昂普拓迈生物科技有限责任公司
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] As we know, metastatic cancer with a poor prognosis is untreatable and is responsible for the majority of cancer patient deaths
Based on the method of SELEX, nucleic acid aptamers have made great breakthroughs in the research of targeted therapy of cancer cells, including liver cancer, colon cancer, colorectal cancer, prostate cancer, etc., but at present, there is no way to distinguish metastatic gastric cancer cells from non-metastatic Nucleic acid aptamers in gastric cancer cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid aptamer specifically binding to metastatic gastric cancer cell, and application thereof
  • Nucleic acid aptamer specifically binding to metastatic gastric cancer cell, and application thereof
  • Nucleic acid aptamer specifically binding to metastatic gastric cancer cell, and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Screening of nucleic acid aptamers specifically binding to metastatic gastric cancer cells

[0033] 1. Synthesize a random single-stranded DNA library and primers shown in the following sequences:

[0034] Random ssDNA library:

[0035] 5'-TTCAGCACTCCACGCATAGC-40N-CCTATGCGTGCTACCGTGAA-3',

[0036] Among them, "40N" represents a sequence formed by connecting 40 arbitrary nucleotide bases, and the library was synthesized by Sangon Bioengineering (Shanghai) Co., Ltd.;

[0037] 5' end primer: 5'-FAM-TTCAGCACTCCACGCATAGC,

[0038] 3' end primer: 5'-(20A)-Spacer 18-TTCACGGTAGCACGCATAGG,

[0039] Among them, "20A" represents a polyA tail composed of 20 adenosine (A), "Spacer 18" represents an 18-atom hexaethylene glycol interarm, and the structural formulas of the three "Spacer 18" are shown in the following formulas I-III , the "Spacer 18" structural formula used in the above 3' end primer is shown in formula I,

[0040]

[0041] The above primers were synthesized by ...

Embodiment 2

[0060] The binding ability and binding position of nucleic acid aptamer LW-25 and metastatic gastric cancer cell HGC-27 were detected by flow cytometry:

[0061] 1. Wash the HGC-27 cells in the logarithmic growth phase twice with PBS, then digest them with enzyme-free digestion solution (APPLYGEN, Beijing) for 5 minutes, break up, centrifuge at 2000rpm, remove the supernatant, and wash with 2ml PBS for 2 Incubate with 400nM FAM-labeled aptamer LW-25 and a random single-stranded DNA library at 4°C for 1 hour;

[0062] 2. At the same time, take the HGC-27 cells in the logarithmic growth phase and wash them twice with PBS, then treat them with 0.25% trypsin digestion solution at 37°C for 5 minutes, then add serum to stop the digestion, break up the cells, and centrifuge at 2000rpm to remove The supernatant was washed twice by centrifugation with 2ml PBS and then incubated with 400nM FAM-labeled nucleic acid aptamer LW-25 at 4°C for 1 hour;

[0063] 3. The cells incubated in step...

Embodiment 3

[0065] Flow cytometry detection of binding specificity of nucleic acid aptamer LW-25 and metastatic gastric cancer cell HGC-27:

[0066] 1. Wash HGC-27 cells, AGS cells, A549 cells, Hep3B cells, sw480 cells, MCF-7 cells, HepG2 cells, and HEK-293 cells in logarithmic growth phase twice with PBS, and then digest them with enzyme-free (APPLYGEN, Beijing) was digested and dispersed, centrifuged at 2000rpm to remove the supernatant, washed twice with 2ml PBS, and then mixed with 400nM FAM-labeled nucleic acid aptamer LW-25 and random single-stranded DNA library at 4°C Incubate for 1 hour;

[0067] 2. The cells incubated in step 1 were washed twice with washing buffer, each time 400 μl, and finally 200 μl of washing buffer was added to resuspend the cells for flow cytometry detection. Test results such as Figure 4 as shown, Figure 4 It is the detection result of binding specificity between nucleic acid aptamer LW-25 and metastatic gastric cancer cell HGC-27; Figure 4 The resu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nucleic acid aptamer specifically binding to a metastatic gastric cancer cell. The sequence of the nucleic acid aptamer comprises at least one of the following four sequences: A, a DNA sequence represented by SEQ ID No.1; B, a DNA sequence having a 60% or more homology with the DNA sequence represented by SEQ ID No.1 and specifically binding to the metastatic gastric cancer cell; C, a DNA sequence hybridized with the DNA sequence represented by SEQ ID No.1 under strict conditions; and D, an RNA sequence transcribed from the DNA sequence represented by SEQ ID No.1. Theinvention also discloses a nucleic acid aptamer derivative. The invention further discloses an application of the nucleic acid aptamer or the nucleic acid aptamer derivative.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a nucleic acid aptamer specifically binding to metastatic gastric cancer cells and its application. Background technique [0002] Metastasis and invasion are the most important signs of malignant tumors and the main factors of death of cancer patients. About 50% of newly diagnosed gastric cancer cases are metastatic lesions, which usually lead to poor prognosis. Tumor cell membrane molecules are closely related to the invasion and metastasis of many malignant tumors. The identification of molecular targets on tumor cell membranes requires efficient molecular probes with good affinity and specificity. [0003] Nucleic acid aptamer (aptamer) refers to the DNA or RNA molecule screened and isolated by exponential enrichment ligand system evolution (SELEX), also known as chemical antibody, which can interact with other targets such as proteins, metal ions, small molecules, etc. , pepti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/115G01N33/574C12N5/09
CPCC12N5/0693C12N15/115C12N2310/16C12N2310/315C12N2310/3181C12N2509/00G01N33/57446
Inventor 罗昭锋方晓娜刘涛王亚雷
Owner 安徽省昂普拓迈生物科技有限责任公司